Linezolid Hexal (Linezolid)

Linezolid is an oxazolidinone antibiotic used to treat infections caused by Gram‑positive bacteria.

• Skin and soft tissue infections: effective against Gram‑positive pathogens, including MRSA, reducing infection severity.
• Community‑acquired bacterial pneumonia: provides coverage for typical and atypical Gram‑positive organisms.
• MRSA infections: targets methicillin‑resistant Staphylococcus aureus strains, facilitating bacterial eradication.

• Linezolid binds to the 23S rRNA of the 50S ribosomal subunit, preventing formation of the initiation complex required for bacterial protein synthesis. By inhibiting the early stage of translation, it halts bacterial growth and leads to bacteriostatic activity against susceptible Gram‑positive organisms. The drug’s unique binding site differs from those of other antibiotic classes, reducing cross‑resistance and enhancing efficacy against resistant strains.

Linezolid may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Nausea: mild gastrointestinal upset.
• Diarrhea: loose stools.
• Headache: transient cranial discomfort.

Serious or Rare Side Effects

• Thrombocytopenia: significant drop in platelet count.
• Peripheral neuropathy: nerve damage causing tingling or numbness.
• Serotonin syndrome: potentially life‑threatening reaction when combined with serotonergic drugs.

When prescribing Linezolid, clinicians should consider several safety precautions to minimize risks.

• Monitor blood counts: watch for thrombocytopenia and anemia during therapy.
• Assess renal and hepatic function: adjust use in patients with impairment.
• Avoid concomitant serotonergic drugs: risk of serotonin syndrome.
• Limit duration of therapy: prolonged use increases neuropathy risk.
• Educate patients on signs of serious reactions: report rash, bleeding, or neuropathic symptoms promptly.
• Store at ambient temperature: keep in original packaging, protect from moisture and light.

Linezolid interacts with several medications; awareness of interaction severity guides clinical management.

Major Interactions (Avoid)

• Selective serotonin reuptake inhibitors (SSRIs), SNRIs, MAO inhibitors: may precipitate serotonin syndrome.
• Tyramine‑rich foods and sympathomimetics: can cause hypertensive crisis when combined with linezolid’s MAO inhibition.

Moderate Interactions (Monitor Closely)

• Warfarin: may enhance anticoagulant effect, requiring INR monitoring.
• Rifampicin: induces metabolism, potentially reducing linezolid levels.
• Ethanol: may increase risk of disulfiram‑like reactions.